Moderna (MRNA) Operating Income Growth (3y) (2020 - 2026)
Moderna (MRNA) Operating Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moderna | 21.94 Bn | 16.73 Bn | -566.00 Mn | -55.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.94% |
| Dec 31, 2025 | -36.48% |
| Sep 30, 2025 | -30.51% |
| Jun 30, 2025 | -33.34% |
| Mar 31, 2025 | -31.01% |
| Dec 31, 2024 | -30.65% |
| Sep 30, 2024 | -26.40% |
| Jun 30, 2024 | -34.72% |
| Mar 31, 2024 | -44.22% |
| Dec 31, 2023 | 26.45% |
| Sep 30, 2023 | -104.58% |
| Jun 30, 2023 | -148.27% |
| Mar 31, 2023 | -40.84% |
| Dec 31, 2022 | 141.60% |
| Sep 30, 2022 | 121.84% |
| Jun 30, 2022 | 166.97% |
| Mar 31, 2022 | 216.96% |
| Dec 31, 2021 | 234.28% |
| Sep 30, 2021 | 251.58% |
| Jun 30, 2021 | 222.56% |